Abstract

The French "Haut Conseil de la santé publique" (High Council for Public Health) recommends that the Intanza® 15 mcg intradermal vaccine against influenza be used for people aged 65 and older, and for people with certain chronic diseases, aged 60 and over, as recommended in the immunization schedule.

Statement issued by the French Commission of experts on communicable diseases (Commission spécialisée maladies transmissibles), on the proposal of the Technical Vaccination Committee (Comité technique des vaccinations - CTV) on May 28, 2010.

Source: http://www.hcsp.fr/docspdf/avisrapports/hcspa20100528_intanza15.pdf

  • Europe
  • France
  • health policy
  • Influenza